2138 — EC Healthcare Income Statement
0.000.00%
Last trade - 00:00
- HK$1.60bn
- HK$2.97bn
- HK$3.88bn
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,852 | 1,949 | 2,080 | 2,920 | 3,875 |
Cost of Revenue | |||||
Gross Profit | 1,625 | 1,733 | 1,845 | 2,570 | 3,322 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,403 | 1,570 | 1,796 | 2,549 | 3,688 |
Operating Profit | 449 | 378 | 285 | 371 | 187 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 450 | 361 | 266 | 321 | 136 |
Provision for Income Taxes | |||||
Net Income After Taxes | 385 | 310 | 226 | 271 | 107 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 361 | 287 | 193 | 198 | 69.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 361 | 287 | 193 | 198 | 69.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.367 | 0.287 | 0.11 | 0.153 | 0.032 |
Dividends per Share | |||||
Special Dividends per Share |